Literature DB >> 27629504

Anticoagulation therapy: Use of edoxaban in cardioversion for AF.

Gregory B Lim.   

Abstract

Entities:  

Year:  2016        PMID： 27629504     DOI： 10.1038/nrcardio.2016.150

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.

Authors:  Andreas Goette; Jose L Merino; Michael D Ezekowitz; Dmitry Zamoryakhin; Michael Melino; James Jin; Michele F Mercuri; Michael A Grosso; Victor Fernandez; Naab Al-Saady; Natalya Pelekh; Bela Merkely; Sergey Zenin; Mykola Kushnir; Jindrich Spinar; Valeriy Batushkin; Joris R de Groot; Gregory Y H Lip
Journal:  Lancet       Date:  2016-08-30       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.